Steven de Jong
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Cell death mechanisms and regulation 64
- Cancer therapeutics and mechanisms 16
- RNA Interference and Gene Delivery 10
- Oncology 63
- Cancer-related Molecular Pathways 29
- Co-authors
- Elisabeth G.E. de Vries (105 shared papers)Jourik A. Gietema (18 shared papers)Harry Hollema (28 shared papers)Mathilde Jalving (18 shared papers)Frank A.E. Kruyt (14 shared papers)Jan J. Koornstra (12 shared papers)G. Bea A. Wisman (25 shared papers)A.G.J. van der Zee (16 shared papers)
- Journals
- British Journal of Cancer (14 papers)International Journal of Cancer (10 papers)The Journal of Pathology (8 papers)Cancer Research (6 papers)Clinical Cancer Research (6 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Steven de Jong
183 papers receiving 9.0k citations
Steven de Jong's Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 1.5k
- Oncology 2.8k
- Molecular Biology 4.6k
- Reproductive Medicine 469
- Immunology 1.1k
Countries citing papers authored by Steven de Jong
This map shows the geographic impact of Steven de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven de Jong more than expected).
Fields of papers citing papers by Steven de Jong
This network shows the impact of papers produced by Steven de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven de Jong. The network helps show where Steven de Jong may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research Hit paper breakdown → | 2014 | 1212 |
| 2 | 2010 | 316 | |
| 3 | Heart Failure Stimulates Tumor Growth by Circulating Factors Hit paper breakdown → | 2018 | 249 |
| 4 | 2008 | 230 | |
| 5 | 2006 | 195 | |
| 6 | 2010 | 174 | |
| 7 | 2006 | 149 | |
| 8 | 2004 | 148 | |
| 9 | 2013 | 146 | |
| 10 | 2004 | 144 | |
| 11 | 2006 | 144 | |
| 12 | 2004 | 137 | |
| 13 | 2009 | 137 | |
| 14 | 2009 | 136 | |
| 15 | 2019 | 129 | |
| 16 | Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors. | 2003 | 122 |
| 17 | 2003 | 120 | |
| 18 | 2008 | 114 | |
| 19 | P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. | 1991 | 107 |
| 20 | 2020 | 105 |
About Steven de Jong
Steven de Jong is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Immunology, having authored 187 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (64 papers), Cancer-related Molecular Pathways (29 papers), Cancer therapeutics and mechanisms (16 papers), Ovarian cancer diagnosis and treatment (14 papers), NF-κB Signaling Pathways (11 papers), RNA Interference and Gene Delivery (10 papers), Cancer Research and Treatments (10 papers) and Testicular diseases and treatments (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (2.8k citations), Molecular Biology (4.6k citations), Reproductive Medicine (469 citations) and Immunology (1.1k citations). Steven de Jong has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Elisabeth G.E. de Vries, Jourik A. Gietema, Harry Hollema, Mathilde Jalving, Frank A.E. Kruyt, Jan J. Koornstra, G. Bea A. Wisman, A.G.J. van der Zee, Ate G.J. van der Zee and Ate G.J. van der Zee. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, The Journal of Pathology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.